Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Killock

Showing results (11-20 of 304) with videos related to

Pageof 31
Sort By:
Nature Reviews. Clinical Oncology|May 23, 2018
CTCs and benefit from radiotherapyDavid Killock
Nature Reviews. Clinical Oncology|October 9, 2021
Tebentafusp for uveal melanomaDavid Killock
Nature Reviews. Clinical Oncology|October 30, 2021
Abemaciclib crowned in monarchEDavid Killock
Nature Reviews. Clinical Oncology|June 27, 2019
BRAF+MEKi and ICI triplets show promise in melanomaDavid Killock
Nature Reviews. Clinical Oncology|September 2, 2018
Signatures IMPRES and might turn the TIDE in predicting responsesDavid Killock
Nature Reviews. Clinical Oncology|September 14, 2016
Immunotherapy: CAR T cells pursue CLL cells and avoid innocent bystandersDavid Killock
Nature Reviews. Clinical Oncology|September 1, 2016
Cell signalling: Melanoma melanosomes shape the stromal nicheDavid Killock
Nature Reviews. Clinical Oncology|April 18, 2018
New subtypes of high-grade neuroendocrine tumours revealedDavid Killock
Nature Reviews. Clinical Oncology|July 8, 2018
Sodium thiosulfate halves the risk of cisplatin-induced hearing lossDavid Killock
Nature Reviews. Clinical Oncology|August 22, 2020
Venetoclax in AML: efficacy confirmedDavid Killock
Pageof 31

Showing results (11-20 of 304) with videos related to

Sort By:
Pageof 31
Nature Reviews. Clinical Oncology|May 23, 2018
CTCs and benefit from radiotherapyDavid Killock
Nature Reviews. Clinical Oncology|October 9, 2021
Tebentafusp for uveal melanomaDavid Killock
Nature Reviews. Clinical Oncology|October 30, 2021
Abemaciclib crowned in monarchEDavid Killock
Nature Reviews. Clinical Oncology|June 27, 2019
BRAF+MEKi and ICI triplets show promise in melanomaDavid Killock
Nature Reviews. Clinical Oncology|September 2, 2018
Signatures IMPRES and might turn the TIDE in predicting responsesDavid Killock
Nature Reviews. Clinical Oncology|September 14, 2016
Immunotherapy: CAR T cells pursue CLL cells and avoid innocent bystandersDavid Killock
Nature Reviews. Clinical Oncology|September 1, 2016
Cell signalling: Melanoma melanosomes shape the stromal nicheDavid Killock
Nature Reviews. Clinical Oncology|April 18, 2018
New subtypes of high-grade neuroendocrine tumours revealedDavid Killock
Nature Reviews. Clinical Oncology|July 8, 2018
Sodium thiosulfate halves the risk of cisplatin-induced hearing lossDavid Killock
Nature Reviews. Clinical Oncology|August 22, 2020
Venetoclax in AML: efficacy confirmedDavid Killock
Pageof 31